Eureka Therapeutics eurekainc.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Eureka Therapeutics is focused on the discovery of fully-human antibody drugs for the treatment of cancer. Utilizing its antibody drug discovery and engineering technologies, Eureka is advancing safe and effective therapies for targeting previously inaccessible cancer antigens. The company has built an early stage pipeline of innovative drugs, with the most advanced candidates at pre-clinical stage in collaboration with Memorial Sloan-Kettering Cancer Center.

Eureka Therapeutics is focused on the discovery of fully-human antibody drugs for the treatment of cancer. Utilizing its antibody drug discovery and engineering technologies, Eureka is advancing safe and effective therapies for targeting previously i...Show all

Company (Alive / Active)

Phone: 510-654-7045

Fax:

5858 Horton Street
Suite 370
Emeryville, 94608
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Eureka Therapeutics $113.8M Jun 18, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Eureka Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
T cell receptor-like antibodies specific for a wti peptide presented by hla-a2 May 28, 2015 Jan 10, 2017 Patent
T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2 Apr 02, 2012 Jul 07, 2015 Patent
Methods for generating host cells Jul 21, 2009 Dec 27, 2011 Patent
Modified host cells and uses thereof Jul 21, 2009 Dec 20, 2011 Patent
Modified glycoproteins and uses thereof Jul 21, 2009 Sep 27, 2011 Patent
See all 22 patents